Drug Database
N07 OTHER NERVOUS SYSTEM DRUGS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- N07AA01 neostigmine
- N07AA02 pyridostigmine
- N07AA51 neostigmine, combinations
- N07AX01 pilocarpine
- N07BA01 nicotine
- N07BA03 varenicline
- N07BB01 disulfiram
- N07BB03 acamprosate
- N07BB04 naltrexone
- N07BB05 nalmefene
- N07BC01 buprenorphine
- N07BC02 methadone
- N07BC06 diamorphine
- N07BC51 buprenorphine, combinations
- N07CA01 betahistine
- N07CA02 cinnarizine
- N07XX02 riluzole
- N07XX04 sodium oxybate
- N07XX05 amifampridine
- N07XX06 tetrabenazine
- N07XX07 fampridine
- N07XX08 tafamidis
- N07XX11 pitolisant
- N07XX12 patisiran
- N07XX15 inotersen
- N07XX18 vutrisiran
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).